نتائج البحث - "Eveline A.M. Heijnsdijk"

81

Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality

المؤلفون: Amy Trentham-Dietz, Clyde B. Schechter, Sylvia K. Plevritis, Yaojen Chang, Oguzhan Alagoz, Mehmet Ali Ergun, Natasha K. Stout, Elizabeth S. Burnside, Brian L. Sprague, Eveline A.M. Heijnsdijk, Donald A. Berry, Harry J. de Koning, Diego F. Munoz, Gary B. Chisholm, Jeanne S. Mandelblatt, Hui Huang, Aimee M. Near, Sandra J. Lee, Nicolien T. van Ravesteyn

المساهمون: Public Health, Epidemiology, Rehabilitation Medicine

المصدر: Journal of the National Cancer Institute, 106(11). Oxford University Press

مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Population, Breast Neoplasms, Context (language use), Disease, Risk Assessment, Sensitivity and Specificity, Article, Breast cancer, SDG 3 - Good Health and Well-being, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Adjuvant therapy, Humans, Mass Screening, Mammography, Survivors, Mortality, education, Early Detection of Cancer, Mass screening, Aged, Neoplasm Staging, education.field_of_study, Models, Statistical, medicine.diagnostic_test, business.industry, Reproducibility of Results, Cancer, Middle Aged, medicine.disease, United States, Receptors, Estrogen, Chemotherapy, Adjuvant, Population Surveillance, Immunology, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::069a585a8f32817c99969ac1e8a61e3e
https://doi.org/10.1093/jnci/dju289

82

Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance Imaging

المؤلفون: Madeleine M.A. Tilanus-Linthorst, Maartje J. Hooning, Harry J. de Koning, Jan C. Oosterwijk, Sepideh Saadatmand, Claudette E. Loo, Inge-Marie Obdeijn, Emiel J. Th. Rutgers, Nicoline Hoogerbrugge, Eveline A.M. Heijnsdijk, Rob A. E. M. Tollenaar

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Surgery, Internal Medicine, Medical Oncology, Radiology & Nuclear Medicine, Public Health

المصدر: Journal of the National Cancer Institute, 105, 1314-1321
JNCI: Journal of the National Cancer Institute, 105(17), 1314-1321
Journal of the National Cancer Institute, 105, 17, pp. 1314-1321
Journal of the National Cancer Institute, 105(17), 1314-1321. Oxford University Press

مصطلحات موضوعية: Oncology, Cancer Research, Cost effectiveness, Cost-Benefit Analysis, Genes, BRCA2, Genes, BRCA1, Breast cancer screening, Risk Factors, Mass Screening, Prospective Studies, Family history, Medical History Taking, skin and connective tissue diseases, Early Detection of Cancer, MAMMOGRAPHIC DENSITY, POPULATION, Netherlands, education.field_of_study, Palpation, medicine.diagnostic_test, Incidence, Middle Aged, Magnetic Resonance Imaging, TUMOR CHARACTERISTICS, Female, Mammography, MRI, Adult, medicine.medical_specialty, Hereditary cancer and cancer-related syndromes Genetics and epigenetic pathways of disease [ONCOL 1], Population, Breast Neoplasms, MUTATION CARRIERS, Risk Assessment, Breast cancer, AGE, SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], Internal medicine, SURVEILLANCE, medicine, Humans, Family, Genetic Predisposition to Disease, COHORT, education, Aged, Hereditary cancer and cancer-related syndromes [ONCOL 1], business.industry, MORTALITY, Cancer, Magnetic resonance imaging, medicine.disease, Mutation, business, FOLLOW-UP

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22de65bdb858bb3c129b34c13f6127a9
http://hdl.handle.net/2066/124514

83

1450 THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY

المؤلفون: Harry J. de Koning, Eveline A.M. Heijnsdijk, Elisabeth M. Wever

المصدر: Journal of Urology. 187

مصطلحات موضوعية: Protocol (science), medicine.medical_specialty, Psa screening, business.industry, Urology, Medicine, business, Intensive care medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::672d57a9a62e0deb12450c7d3d407be9
https://doi.org/10.1016/j.juro.2012.02.1944

View record from ScienceDirect

84

Le dépistage est-il responsable du surdiagnostic? Comment le mesurer?

المؤلفون: Eveline A.M. Heijnsdijk, H.J. de Koning, Gerrit Draisma, J. Fracheboud, R. de Gelder

المصدر: Cancer du sein : surdiagnostic, surtraitement ISBN: 9782817802480

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fe8d53a3ddc688a9e63786a337a0f0cf
https://doi.org/10.1007/978-2-8178-0249-7_3

85

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

المؤلفون: Sepideh Saadatmand, Margreet S. Schlooz-Vries, Caroline Seynaeve, Margreet G. E. M. Ausems, Linetta B. Koppert, Madeleine M.A. Tilanus-Linthorst, Hermien M. Zonderland, Inge-Marie Obdeijn, Eveline A.M. Heijnsdijk, Kristien Keymeulen, Rob A. E. M. Tollenaar, Harry J. de Koning, Cees Verhoef, Emiel J. Th. Rutgers, Jan C. Oosterwijk

المساهمون: Surgery, Public Health, Medical Oncology, Radiology & Nuclear Medicine, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), RS: NUTRIM - R2 - Gut-liver homeostasis, Radiology and Nuclear Medicine

المصدر: BMC Cancer, 12(440). BioMed Central Ltd.
BMC Cancer, 12:440. BMC
BMC Cancer, 12
BMC Cancer, 12:440. BioMed Central Ltd
BMC Cancer
BMC Cancer, Vol 12, Iss 1, p 440 (2012)
BMC cancer, 12(1). BioMed Central

مصطلحات موضوعية: Cancer Research, Cost effectiveness, law.invention, COST-EFFECTIVENESS, Study Protocol, Breast cancer screening, Breast cancer, Clinical Protocols, Randomized controlled trial, Risk Factors, law, BRCA2 MUTATION CARRIERS, Family history, skin and connective tissue diseases, Early Detection of Cancer, POPULATION, ULTRASOUND, education.field_of_study, medicine.diagnostic_test, Obstetrics, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Magnetic Resonance Imaging, Oncology, CARCINOMA IN-SITU, Screening, Breast density, Female, Mammography, MRI, Adult, medicine.medical_specialty, Population, Breast Neoplasms, DIAGNOSIS, lcsh:RC254-282, Quality of Care [ONCOL 4], SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], SURVEILLANCE, Genetics, medicine, Humans, COHORT, education, Familial risk, Gynecology, business.industry, Carcinoma in situ, MORTALITY, medicine.disease, business, FOLLOW-UP

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1880618e7fa60f65e5c082c9415f630
https://pure.eur.nl/en/publications/ca6b33c7-7fbd-49f7-b13c-533babf108ff

Find this article in full text from ProQuest

86

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

المساهمون: Public Health, Surgery, Medical Oncology, Radiology and nuclear medicine, CCA - Disease profiling, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)

المصدر: Heijnsdijk, E A M, Warner, E, Gilbert, F J, Tilanus-Linthorst, M M A, Evans, G, Causer, P A, Eeles, R A, Kaas, R, Draisma, G, Ramsay, E A, Warren, R M L, Hill, K A, Hoogerbrugge, N, Wasser, M N J M, Bergers, E, Oosterwijk, J C, Hooning, M J, Rutgers, E J T, Klijn, J G M, Plewes, D B, Leach, M O & Koning, H J 2012, ' Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined ', Cancer Epidemiology Biomarkers and Prevention, vol. 21, no. 9, pp. 1458-1468 . https://doi.org/10.1158/1055-9965.EPI-11-1196
Cancer Epidemiology, Biomarkers & Prevention, 21, 1458-68
Cancer Epidemiology Biomarkers & Prevention, 21(9), 1458-1468. American Association for Cancer Research Inc.
Cancer Epidemiology Biomarkers and Prevention, 21(9), 1458-1468. American Association for Cancer Research Inc.
Cancer Epidemiology, Biomarkers & Prevention, 21, 9, pp. 1458-68
Cancer Epidemiology, Biomarkers and Prevention, 21(9), 1458-1468
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(9), 1458-1468. AMER ASSOC CANCER RESEARCH

مصطلحات موضوعية: Adult, Oncology, PENETRANCE, Canada, Heterozygote, medicine.medical_specialty, endocrine system diseases, Epidemiology, Cost effectiveness, Hereditary cancer and cancer-related syndromes Genetics and epigenetic pathways of disease [ONCOL 1], Genes, BRCA2, Genes, BRCA1, GENETIC PREDISPOSITION, Breast Neoplasms, OVARIAN-CANCER, COST-EFFECTIVENESS, MAMMOGRAPHY, Breast cancer screening, PROSPECTIVE MULTICENTER COHORT, SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], Internal medicine, SURVEILLANCE, medicine, Humans, Mammography, FAMILIAL RISK, skin and connective tissue diseases, UNITED-KINGDOM, Early Detection of Cancer, Aged, Gynecology, Hereditary cancer and cancer-related syndromes [ONCOL 1], medicine.diagnostic_test, business.industry, WOMEN, Cancer, Middle Aged, Ductal carcinoma, medicine.disease, Magnetic Resonance Imaging, Penetrance, Mutation, Mutation (genetic algorithm), Female, business, Ovarian cancer